Standard
FDA Clears AI-Powered Biometric Tool to Assist Clinicians in Diagnosing Autism
Federal regulators have cleared a novel artificial intelligence and biometric tool designed to assist clinicians in identifying children with autism, marking another step forward in the technological landscape of developmental disability screening. The Food and Drug Administration cleared the diagnostic support tool, known as Neurora, to inform clinical decisions regarding children between the ages of…
